While it has previously been reported that cell surface EGFR promotes cell growth, and that internalization of the EGFR induces cell death in breast cancer cells [37], our present findings suggest that cell surface EGFR retained after Y27632 treatment exerts pro-proliferative signals. Here, EGFR is linked to breast carcinoma.